Аналіз міопатій, пов’язаних з мітохондріальною дисфункцією
DOI:
https://doi.org/10.29038/NCBio.21.2.45-54Keywords:
Citespace, алкогольна міопатія, статини і стероїди, мітохондріальна дисфункціяAbstract
Баланс синтезу і споживання білка в м’язах значною мірою залежить від нормальної функції мітохондрій. Мітохо-ндріальна дисфункція невіддільна від виникнення міопатії. У цьому дослідженні аналізуються взаємозв’язки між міопатією, яка ін-дукована статинами, стероїдною міопатією та захворюванням скелетних м’язів, спричиненим алкогольною залежністю, а також взаємозв’язок між цими станами та мітохондріальними аномаліями.
Центральний архів Web of Science (WOS) був проаналізований на предмет досліджень алкогольної міопатії з 1999 по 2021 рік, бази даних CiteSpace і WOS використовувалися для оцінки кількості написаних статей, розподілу публікацій за регіонами, дослідницьких організацій, аналізу спільно цитованої літератури та ідентифікація ключового слова.
Загалом, після аналізу було виділено 1255 публікацій, при цьому кількість опублікованих статей постійно збільшується. Се-редньорічна кількість публікацій – 54,56. Більшість літератури публікують шість країн. Загалом Сполучені Штати опублікували 383 статтей, що займає перше місце серед усіх країн. Вони також займають центральну позицію у цій сфері досліджень, тобто інші країни більше використовують їх наукові досягнення. Виділено 34 основних автори та 238 статей. За допомогою кластерного ана-лізу виділено 9 категорій, які є значущими кластерами. Ключові слова дослідження спільної появи показують, що такі ключові сло-ва, як наночастинки, апоптоз, мітохондріальні порушення та запалення, є дуже поширеними.
References
1. Kim, K., Anderson, E. M., Scali, S. T. & Ryan, T. E. Skeletal Muscle Mitochondrial Dysfunction and Oxidative Stress in Peripheral Arterial Disease: A Unifying Mechanism and Therapeutic Target. Antioxidants 9, 2020; p. 1304.
2. Tarnopolsky, M. A. & Raha, S. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med-icine and science in sports and exercise 37, 2005; pp. 2086–2093.
3. Sahebkar, A. et al. Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system. Journal of Cachexia, Sarcopenia and Muscle 11, 2020; pp. 1177–1186.
4. Zhang, X. et al. Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension 55, 2010; pp. 1412–1417.
5. Endo, I. et al. Deletion of Vitamin D Receptor Gene in Mice Results in Abnormal Skeletal Muscle Development with Deregulated Expression of Myoregulatory Transcription Factors. Endocrinology 144, 2003; pp. 5138–5144; 10.1210/en.2003-0502 .
6. Couillard, A. Maltais F, Saey D, Debigaré R, Michaud A, Koechlin C, LeBlanc P, Préfaut C. Exercise-induced quadri-ceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstrucyive pulmonary disease. Am J Respir Crit Care Med 167, 2003; pp. 1664–1669.
7. Thompson, P. D., Clarkson, P. & Karas, R. H. Statin-associated myopathy. Jama 289, 2003; pp. 1681–1690.
8. Fernandez-Sola, J. et al. Patients with chronic glucocorti-coid treatment develop changes in muscle glycogen me-tabolism. Journal of the neurological sciences 117, 1993; pp. 103–106.
9. Liu, J. et al. Mitochondrial Dysfunction Launches Dexame-thasone-Induced Skeletal Muscle Atrophy via AMPK/FOXO3 Signaling. Molecular Pharmaceutics 13, 2016; pp. 73–84; 10.1021/acs.molpharmaceut.5b00516.
10. Chen, C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. Journal of the American Society for information Science and Tech-nology 57, 2006; pp. 359–377.
11. Chen, C., Hu, Z., Liu, S. & Tseng, H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert opinion on biological therapy 12, 2012; pp. 593–608.
12. Ochala, J. & Sun, Y.-B. Novel myosin-based therapies for congenital cardiac and skeletal myopathies. Journal of Med-ical Genetics 53, 2016; pp. 651–654; 10.1136/jmedgenet-2016-103881.
13. Salem, R. O., Laposata, M., Rajendram, R., Cluette-Brown, J. E. & Preedy, V. R. THE TOTAL BODY MASS OF FATTY ACID ETHYL ESTERS IN SKELETAL MUSCLES FOL-LOWING ETHANOL EXPOSURE GREATLY EXCEEDS THAT FOUND IN THE LIVER AND THE HEART. Alcohol and Alcoholism 41, 2006; pp. 598–603; 10.1093/alcalc/agl069.
14. Adachi, J. et al. 7alpha- and 7beta-Hydroperoxycholest-5-en-3beta-ol in Muscle as Indices of Oxidative Stress: Re-sponse to Ethanol Dosage in Rats. Alcoholism: Clinical and Experimental Research 24, 2000; pp. 675–681; 10.1111/j.1530-0277. 2000.tb02039.x.
15. Lang, C. H., Frost, R. A., Svanberg, E. & Vary, T. C. IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats. American Journal of Physiology-Endocrinology and Metabolism 286, 2004; pp. E916‐E926; 10.1152/ajpendo.00554.2003.
16. Fernandez-Sola, J. et al. Muscle Antioxidant Status in Chronic Alcoholism. Alcoholism: Clinical and Experimental Research 26, 2002; pp. 1858–1862; 10.1111/j.1530-0277.2002.tb02493.x.
17. Nowak, K. J., Ravenscroft, G. & Laing, N. G. Skeletal muscle α-actin diseases (actinopathies): pathology and mechanisms. Acta Neuropathologica 125, 2013; pp. 19–32; 10.1007/s00401-012-1019-z.
18. Gomes, M. J. et al. Beneficial Effects of Physical Exercise on Functional Capacity and Skeletal Muscle Oxidative Stress in Rats with Aortic Stenosis-Induced Heart Failure. Oxida-tive Medicine and Cellular Longevity 2016, pp. 1–12; 10.1155/2016/ 8695716.
19. Preedy, V. R. et al. Alcoholic skeletal muscle myopathy: defi¬ni¬tions, features, contribution of neuropathy, impact and diagnosis. European Journal of Neurology 8, 2001; pp. 677–687; 10.1046/j.1468-1331.2001.00303.x.
20. Laufs, U. et al. Treatment Options for Statin-Associated Muscle Symptoms. Deutsches Aerzteblatt Online, 2015; 10.3238/ arztebl.2015.0748.
21. Gomes, M. J. et al. Skeletal muscle aging: influence of oxidative stress and physical exercise. Oncotarget 8, 2017; pp. 20428–20440; 10.18632/oncotarget.14670.
22. Gavazzi, A., Maria, R. de, Parolini, M. & Porcu, M. Alcohol abuse and dilated cardiomyopathy in men. The American Journal of Cardiology 85, 2000; pp. 1114–1118; 10.1016/S0002-9149(00)00706-2.
23. Glerup, H. et al. Hypovitaminosis D Myopathy Without Bio¬che¬mical Signs of Osteomalacic Bone Involvement. Calcified Tissue International 66, 2000; pp. 419–424; 10.1007/s002230010085.
24. Moßhammer, D., Schaeffeler, E., Schwab, M. & Mörike, K. Mechanisms and assessment of statin-related muscular ad-verse effects: Statin-related myopathy. British Journal of Clinical Pharmacology 78, 2014; pp. 454–466; 10.1111/bcp.12360.
25. Oshima, Y., Kuroda, Y., Kunishige, M., Matsumoto, T. & Mitsui, T. Oxidative stress-associated mitochondrial dys-function in corticosteroid-treated muscle cells. Muscle & Nerve 30, 2004; pp. 49–54; 10.1002/mus.20036.
26. Wajner, M. & Amaral, A. U. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and an-imal studies. Bioscience Reports 36, 2016; p. e00281; 10.1042/ BSR20150240.
27. 水溶性富勒烯纳米粒子抗氧化活性研究及其肿瘤靶向给药系统的构建. 硕士. 宜春学院. [Zhou, X. Studies on anti-oxidant actactivity of water-soluble fullerene nanoparticles and their construction as tumor targeting drug Studies on antioxidant activity of water-soluble fullerene nanoparticles and their construction as tumor targeting drug, 2020] [in Chinese].
28. Jia, L., Hao, S.-L. & Yang, W.-X. Nanoparticles induce auto¬phagy via mTOR pathway inhibition and reactive oxygen species generation. Nanomedicine 15, 2020; pp. 1419–1435; 10.2217/nnm-2019-0387.
29. Afeseh Ngwa, H. et al. Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicology and Applied Pharmacology 256, 2011; pp. 227–240; 10.1016/j.taap.2011.07.018.
30. Manzo-Avalos, S. & Saavedra-Molina, A. Cellular and mito-chondrial effects of alcohol consumption. International journal of environmental research and public health 7, 2010; pp. 4281–4304.
31. Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Singh, F. & Krähenbühl, S. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacological research 154, 2010; 104201.
2. Tarnopolsky, M. A. & Raha, S. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med-icine and science in sports and exercise 37, 2005; pp. 2086–2093.
3. Sahebkar, A. et al. Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system. Journal of Cachexia, Sarcopenia and Muscle 11, 2020; pp. 1177–1186.
4. Zhang, X. et al. Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension 55, 2010; pp. 1412–1417.
5. Endo, I. et al. Deletion of Vitamin D Receptor Gene in Mice Results in Abnormal Skeletal Muscle Development with Deregulated Expression of Myoregulatory Transcription Factors. Endocrinology 144, 2003; pp. 5138–5144; 10.1210/en.2003-0502 .
6. Couillard, A. Maltais F, Saey D, Debigaré R, Michaud A, Koechlin C, LeBlanc P, Préfaut C. Exercise-induced quadri-ceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstrucyive pulmonary disease. Am J Respir Crit Care Med 167, 2003; pp. 1664–1669.
7. Thompson, P. D., Clarkson, P. & Karas, R. H. Statin-associated myopathy. Jama 289, 2003; pp. 1681–1690.
8. Fernandez-Sola, J. et al. Patients with chronic glucocorti-coid treatment develop changes in muscle glycogen me-tabolism. Journal of the neurological sciences 117, 1993; pp. 103–106.
9. Liu, J. et al. Mitochondrial Dysfunction Launches Dexame-thasone-Induced Skeletal Muscle Atrophy via AMPK/FOXO3 Signaling. Molecular Pharmaceutics 13, 2016; pp. 73–84; 10.1021/acs.molpharmaceut.5b00516.
10. Chen, C. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. Journal of the American Society for information Science and Tech-nology 57, 2006; pp. 359–377.
11. Chen, C., Hu, Z., Liu, S. & Tseng, H. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace. Expert opinion on biological therapy 12, 2012; pp. 593–608.
12. Ochala, J. & Sun, Y.-B. Novel myosin-based therapies for congenital cardiac and skeletal myopathies. Journal of Med-ical Genetics 53, 2016; pp. 651–654; 10.1136/jmedgenet-2016-103881.
13. Salem, R. O., Laposata, M., Rajendram, R., Cluette-Brown, J. E. & Preedy, V. R. THE TOTAL BODY MASS OF FATTY ACID ETHYL ESTERS IN SKELETAL MUSCLES FOL-LOWING ETHANOL EXPOSURE GREATLY EXCEEDS THAT FOUND IN THE LIVER AND THE HEART. Alcohol and Alcoholism 41, 2006; pp. 598–603; 10.1093/alcalc/agl069.
14. Adachi, J. et al. 7alpha- and 7beta-Hydroperoxycholest-5-en-3beta-ol in Muscle as Indices of Oxidative Stress: Re-sponse to Ethanol Dosage in Rats. Alcoholism: Clinical and Experimental Research 24, 2000; pp. 675–681; 10.1111/j.1530-0277. 2000.tb02039.x.
15. Lang, C. H., Frost, R. A., Svanberg, E. & Vary, T. C. IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats. American Journal of Physiology-Endocrinology and Metabolism 286, 2004; pp. E916‐E926; 10.1152/ajpendo.00554.2003.
16. Fernandez-Sola, J. et al. Muscle Antioxidant Status in Chronic Alcoholism. Alcoholism: Clinical and Experimental Research 26, 2002; pp. 1858–1862; 10.1111/j.1530-0277.2002.tb02493.x.
17. Nowak, K. J., Ravenscroft, G. & Laing, N. G. Skeletal muscle α-actin diseases (actinopathies): pathology and mechanisms. Acta Neuropathologica 125, 2013; pp. 19–32; 10.1007/s00401-012-1019-z.
18. Gomes, M. J. et al. Beneficial Effects of Physical Exercise on Functional Capacity and Skeletal Muscle Oxidative Stress in Rats with Aortic Stenosis-Induced Heart Failure. Oxida-tive Medicine and Cellular Longevity 2016, pp. 1–12; 10.1155/2016/ 8695716.
19. Preedy, V. R. et al. Alcoholic skeletal muscle myopathy: defi¬ni¬tions, features, contribution of neuropathy, impact and diagnosis. European Journal of Neurology 8, 2001; pp. 677–687; 10.1046/j.1468-1331.2001.00303.x.
20. Laufs, U. et al. Treatment Options for Statin-Associated Muscle Symptoms. Deutsches Aerzteblatt Online, 2015; 10.3238/ arztebl.2015.0748.
21. Gomes, M. J. et al. Skeletal muscle aging: influence of oxidative stress and physical exercise. Oncotarget 8, 2017; pp. 20428–20440; 10.18632/oncotarget.14670.
22. Gavazzi, A., Maria, R. de, Parolini, M. & Porcu, M. Alcohol abuse and dilated cardiomyopathy in men. The American Journal of Cardiology 85, 2000; pp. 1114–1118; 10.1016/S0002-9149(00)00706-2.
23. Glerup, H. et al. Hypovitaminosis D Myopathy Without Bio¬che¬mical Signs of Osteomalacic Bone Involvement. Calcified Tissue International 66, 2000; pp. 419–424; 10.1007/s002230010085.
24. Moßhammer, D., Schaeffeler, E., Schwab, M. & Mörike, K. Mechanisms and assessment of statin-related muscular ad-verse effects: Statin-related myopathy. British Journal of Clinical Pharmacology 78, 2014; pp. 454–466; 10.1111/bcp.12360.
25. Oshima, Y., Kuroda, Y., Kunishige, M., Matsumoto, T. & Mitsui, T. Oxidative stress-associated mitochondrial dys-function in corticosteroid-treated muscle cells. Muscle & Nerve 30, 2004; pp. 49–54; 10.1002/mus.20036.
26. Wajner, M. & Amaral, A. U. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and an-imal studies. Bioscience Reports 36, 2016; p. e00281; 10.1042/ BSR20150240.
27. 水溶性富勒烯纳米粒子抗氧化活性研究及其肿瘤靶向给药系统的构建. 硕士. 宜春学院. [Zhou, X. Studies on anti-oxidant actactivity of water-soluble fullerene nanoparticles and their construction as tumor targeting drug Studies on antioxidant activity of water-soluble fullerene nanoparticles and their construction as tumor targeting drug, 2020] [in Chinese].
28. Jia, L., Hao, S.-L. & Yang, W.-X. Nanoparticles induce auto¬phagy via mTOR pathway inhibition and reactive oxygen species generation. Nanomedicine 15, 2020; pp. 1419–1435; 10.2217/nnm-2019-0387.
29. Afeseh Ngwa, H. et al. Manganese nanoparticle activates mitochondrial dependent apoptotic signaling and autophagy in dopaminergic neuronal cells. Toxicology and Applied Pharmacology 256, 2011; pp. 227–240; 10.1016/j.taap.2011.07.018.
30. Manzo-Avalos, S. & Saavedra-Molina, A. Cellular and mito-chondrial effects of alcohol consumption. International journal of environmental research and public health 7, 2010; pp. 4281–4304.
31. Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Singh, F. & Krähenbühl, S. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacological research 154, 2010; 104201.
Downloads
Published
2022-02-03
Issue
Section
Human and Animal Physiology
How to Cite
Аналіз міопатій, пов’язаних з мітохондріальною дисфункцією. (2022). Notes in Current Biology, 2(2), 45-54. https://doi.org/10.29038/NCBio.21.2.45-54
